• Practical Use of Hydrocortisone (B1951) in Experimental Work

  2026-05-08

  Hydrocortisone is a gold-standard glucocorticoid hormone for dissecting glucocorticoid receptor signaling, inflammation models, and stress response mechanisms. It is recommended for protocols demanding validated anti-inflammatory pathway modulation but should not be applied where precise aqueous solubility or long-term solution stability is mandatory. Use is best restricted to workflows familiar with DMSO-based solubilization and rapid preparation cycles.

• Hydrogel-Delivered Exosome-Like Nanovesicles Enhance Oral Mu

  2026-05-07

  Wei et al. introduce a semi-IPN hydrogel system that deploys homologous drug-loaded exosome-like nanovesicles to accelerate wound healing in chemoradiotherapy-induced oral mucositis. This strategy improves oridonin delivery, enhances biocompatibility, and offers significant therapeutic potential for mucosal injuries resulting from cancer therapies.

• Tamoxifen (SKU B5965): Reliable SERM for Advanced Lab Assays

  2026-05-07

  This article delivers scenario-driven insights into using Tamoxifen (SKU B5965) for cell viability, proliferation, and gene knockout workflows. It highlights evidence-based best practices, addresses common laboratory challenges, and clarifies why APExBIO’s high-purity Tamoxifen is a trusted choice for reproducibility and data integrity.

• Hydrocortisone in Applied Inflammation Models: Protocols & P

  2026-05-06

  Hydrocortisone stands out as a gold-standard glucocorticoid hormone for dissecting inflammation, immune modulation, and stress response mechanisms in both cellular and animal models. This guide details actionable workflows, innovative applications, and practical troubleshooting strategies that leverage APExBIO's high-purity Hydrocortisone, empowering researchers to achieve reproducible, high-impact results.

• Antidepressant Effects of Rotigotine: Insights from Animal M

  2026-05-06

  This study demonstrates that Rotigotine, a dopamine D2/D3 receptor agonist, exhibits antidepressant-like activity in multiple validated rodent models of depression. The work advances understanding of dopaminergic modulation in mood disorders and offers translational cues for Parkinson’s disease research.

• Fluconazole: Protocol Optimization for Antifungal Susceptibi

  2026-05-05

  Harnessing APExBIO’s Fluconazole, researchers can dissect ergosterol biosynthesis inhibition and fungal drug resistance with unmatched reproducibility. This guide delivers workflow-centric protocols, quantitative troubleshooting, and comparative insights for advanced antifungal susceptibility and pathogenesis research.

• cgSHAPE-seq Maps SARS-CoV-2 RNA Degrader Binding Sites

  2026-05-05

  This study introduces cgSHAPE-seq, a sequencing-based method to pinpoint small molecule binding sites in structured viral RNAs. By applying this approach to the SARS-CoV-2 5’ UTR, the authors identify a conserved bulged guanosine in SL5 as a critical target for RNA-degrading chimeras, offering a new strategy for antiviral development.

• Angiotensin Peptides Modulate SARS-CoV-2 Spike–Receptor Bind

  2026-05-04

  This study demonstrates that naturally occurring angiotensin peptides, including short C- and N-terminal fragments, significantly enhance SARS-CoV-2 spike protein binding to the AXL receptor, implicating a new facet of the renin–angiotensin system in viral pathogenesis. These findings suggest a mechanistic bridge between cardiovascular peptide signaling and COVID-19 infectivity, informing both therapeutic targeting and peptide research strategies.

• AICAR phosphate (Acadesine): Reliable AMPK Activation in B-C

  2026-05-04

  This article addresses critical laboratory challenges in cell viability and apoptosis assays by providing evidence-based answers on AICAR phosphate (Acadesine), SKU B1211. It guides biomedical researchers and lab technicians through real-world scenarios, focusing on the compound’s reproducibility, mechanism, and workflow compatibility. The content emphasizes the value of high-purity AICAR phosphate (Acadesine) from APExBIO for sensitive, quantitative research in B-cell chronic lymphocytic leukemia.

• AG-221 (Enasidenib): Targeted IDH2 Inhibition in AML Researc

  2026-05-03

  AG-221 (Enasidenib) is a selective inhibitor of mutant IDH2, validated for reducing 2-hydroxyglutarate in acute myeloid leukemia models. It reverses epigenetic dysregulation and induces leukemia cell differentiation. This article details its biological rationale, mechanism, and workflow integration for AML research.

• O-GlcNAcylation as a Key Mediator of Wnt-Stimulated Bone For

  2026-05-02

  This study demonstrates that O-GlcNAcylation is essential for Wnt3a-driven bone anabolism by modulating glycolytic metabolism in osteoblasts. The findings reveal a critical mechanistic link between Wnt signaling, protein O-GlcNAcylation, and bone tissue regeneration, with implications for osteoporosis research and metabolic bone disease models.

• 3D Nanotube-in-Micropillar Electrodes Enable Size-Independen

  2026-05-02

  This study introduces a robust three-dimensional nanotube-in-micropillar electrode system that achieves efficient, size-independent electroporation for blood cell therapy. The approach permits effective non-viral delivery of genetic material into heterogeneous blood cell populations, offering a safer and more versatile alternative to viral transduction.

• WY-14643 (Pirinixic Acid): Precision Metabolic Research Unlo

  2026-05-01

  WY-14643 (Pirinixic Acid) is a benchmark tool for dissecting PPARα-driven lipid regulation and liver regeneration. Recent reference studies reveal new mechanistic links to YAP-TEAD signaling, enabling advanced metabolic and anti-inflammatory workflows that surpass conventional PPAR research approaches.

• Live-Dead Cell Staining Kit I: Precision in Mammalian Cell V

  2026-04-30

  Unravel advanced workflows and troubleshooting strategies with the Live-Dead Cell Staining Kit I (Calcein AM/PI) for robust mammalian cell viability and cytotoxicity assessment. Discover how this kit uniquely empowers ferroptosis and oncology research through real-world use-cases and protocol enhancements.

• NADPH Oxidase-Derived ROS Drive Arterial Contraction via LTC

  2026-04-30

  This study reveals that NADPH oxidase-derived reactive oxygen species (ROS) enhance arterial contraction in early postnatal rats through the activation of L-type voltage-gated Ca2+ channels (LTCC), rather than through Rho-kinase, PKC, or Src-kinase pathways. These findings clarify age-dependent mechanisms of vascular tone regulation and provide a foundation for future research on neonatal cardiovascular physiology.

453 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page